More than 30,000 patients with Type 1 diabetes across the UK Midlands now have access to life-changing continuous glucose monitoring technology, thanks to cost-effective deals
The US Food and Drug Administration has approved Abbott’s Proclaim XR spinal cord stimulation (SCS) system for the treatment of patients with diabetic peripheral neuropathy
Patient numbers published recently by the independent OCL Vision eye clinic reveal a surging demand for private eye surgery as NHS waiting lists break new
As icy cold snaps make for challenging conditions on the roads, a high street optician is urging people to ‘get themselves seen’ after more than
Another recent survey on eye care – this time by polling organisation YouGov – has concluded that the pandemic and cost-of-living crisis are having a
The January and February cold snaps saw temperatures drop below freezing in certain areas of the UK, but a free support service called the Priority
The Royal Mail has teamed up with Pharmacy2U, the UK’s largest online pharmacy, to offer a complete NHS prescription service that enables patients to order
Ypsomed and Mediq are completing the sale of DiaExpert. Ypsomed and Mediq had announced the agreement on the sale of DiaExpert on 28 October 2022.
Oramed Pharmaceuticals has announced that it has received a new patent for its oral diabetes treatment. The patent covers oral pharmaceutical compositions comprising insulin in
The US Food and Drug Administration has approved a new medication for Type 2 diabetes called Brenzavvy. This belongs to a class of drugs known
